S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver

Kiniksa Pharmaceuticals (KNSA) Short Interest Ratio & Short Volume

$16.81
+0.64 (+3.96%)
(As of 12/1/2023 ET)
Compare
Today's Range
$16.04
$16.83
50-Day Range
$14.37
$17.61
52-Week Range
$10.29
$20.65
Volume
426,817 shs
Average Volume
387,526 shs
Market Capitalization
$1.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.50

Kiniksa Pharmaceuticals Short Interest Data

Current Short Volume
3,410,000 shares
Previous Short Volume
3,210,000 shares
Change Vs. Previous Month
+6.23%
Dollar Volume Sold Short
$53.64 million
Short Interest Ratio / Days to Cover
10.3
Last Record Date
November 15, 2023
Outstanding Shares
70,340,000 shares
Percentage of Shares Shorted
4.85%
Today's Trading Volume
426,817 shares
Average Trading Volume
387,526 shares
Today's Volume Vs. Average
110%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Kiniksa Pharmaceuticals ?

Sign up to receive the latest short interest report for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

KNSA Short Interest Over Time

KNSA Days to Cover Over Time

KNSA Percentage of Float Shorted Over Time


Kiniksa Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/20233,410,000 shares $53.64 million +6.2%N/A10.3 $15.73
10/31/20233,210,000 shares $48.95 million -17.7%N/A9.5 $15.25
10/15/20233,900,000 shares $63.61 million +0.8%N/A8.8 $16.31
9/30/20233,870,000 shares $67.22 million +1.3%N/A8.2 $17.37
9/15/20233,820,000 shares $65.47 million -0.8%N/A8 $17.14
8/31/20233,850,000 shares $66.34 million -1.5%N/A7.5 $17.23
8/15/20233,910,000 shares $64.91 million +13.7%N/A7.3 $16.60
7/31/20233,440,000 shares $64.81 million +30.8%N/A6.4 $18.84
7/15/20232,630,000 shares $38.21 million -1.1%N/A5.3 $14.53
6/30/20232,660,000 shares $37.45 million -2.9%N/A6.6 $14.08
6/15/20232,740,000 shares $44.83 million +3.4%N/A6.7 $16.36
5/31/20232,650,000 shares $36.73 million -4.7%N/A6.3 $13.86
5/15/20232,780,000 shares $39.89 million -11.5%N/A6.5 $14.35
4/30/20233,140,000 shares $33.76 million +8.3%N/A7.5 $10.75
4/15/20232,900,000 shares $32.92 million -3.7%N/A7.6 $11.35
3/31/20233,010,000 shares $32.39 million +19.4%N/A7.7 $10.76
3/15/20232,520,000 shares $28.78 million -7.4%N/A6.7 $11.42
2/28/20232,720,000 shares $34.98 million -0.4%N/A7.6 $12.86
2/15/20232,730,000 shares $36.80 million -0.7%N/A7.9 $13.48
1/31/20232,750,000 shares $39.77 million -4.8%N/A7.5 $14.46
1/15/20232,890,000 shares $42.05 million +2.5%N/A7.7 $14.55
12/30/20222,820,000 shares $42.24 million +38.2%N/A7.3 $14.98
12/15/20222,040,000 shares $32.19 million -22.7%N/A5.3 $15.78
11/30/20222,640,000 shares $44.43 million -5.4%N/A7.5 $16.83
11/15/20222,790,000 shares $43.97 million +2.2%N/A8.1 $15.76
10/31/20222,730,000 shares $31.18 million +3.0%N/A8.2 $11.42
10/15/20222,650,000 shares $35.96 million -8.0%N/A7.8 $13.57
9/30/20222,880,000 shares $36.98 million +18.5%N/A8.2 $12.84
9/15/20222,430,000 shares $25.44 million +7.5%N/A7.8 $10.47
8/31/20222,260,000 shares $26.49 million +15.3%N/A6.9 $11.72
8/15/20221,960,000 shares $24.42 million +1.6%N/A5.9 $12.46
7/31/20221,930,000 shares $19.13 million -18.2%N/A5.7 $9.91
7/15/20222,360,000 shares $26.55 million -2.9%N/A8.3 $11.25
6/30/20222,430,000 shares $23.55 million -4.7%N/A8.9 $9.69
6/15/20222,550,000 shares $21.78 million +2.4%N/A9.2 $8.54
5/31/20222,490,000 shares $19.07 million +1.6%N/A8.1 $7.66
5/15/20222,450,000 shares $20.14 million +7.0%N/A7.7 $8.22
4/30/20222,290,000 shares $21.37 million -0.9%N/A7.3 $9.33
4/15/20222,310,000 shares $25.94 million -10.5%N/A7 $11.23
3/31/20222,580,000 shares $25.65 million -20.9%N/A7.3 $9.94













KNSA Short Interest - Frequently Asked Questions

What is Kiniksa Pharmaceuticals' current short interest?

Short interest is the volume of Kiniksa Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 3,410,000 shares of KNSA short. Learn More on Kiniksa Pharmaceuticals' current short interest.

What is a good short interest ratio for Kiniksa Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KNSA shares currently have a short interest ratio of 10.0. Learn More on Kiniksa Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Kiniksa Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kiniksa Pharmaceuticals: Citigroup Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Kiniksa Pharmaceuticals' short interest increasing or decreasing?

Kiniksa Pharmaceuticals saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 3,410,000 shares, an increase of 6.2% from the previous total of 3,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Kiniksa Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kiniksa Pharmaceuticals: Syndax Pharmaceuticals, Inc. (15.25%), Xencor, Inc. (10.28%), Arcus Biosciences, Inc. (12.49%), Morphic Holding, Inc. (12.28%), Geron Co. (8.19%), Viking Therapeutics, Inc. (16.96%), Belite Bio, Inc (0.32%), Avadel Pharmaceuticals plc (5.31%), ANI Pharmaceuticals, Inc. (1.84%), Protagonist Therapeutics, Inc. (6.33%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Kiniksa Pharmaceuticals stock?

Short selling KNSA is an investing strategy that aims to generate trading profit from Kiniksa Pharmaceuticals as its price is falling. KNSA shares are trading up $0.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Kiniksa Pharmaceuticals?

A short squeeze for Kiniksa Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KNSA, which in turn drives the price of the stock up even further.

How often is Kiniksa Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KNSA, twice per month. The most recent reporting period available is November, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:KNSA) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -